LOCOID
LOE ApproachingNDATOPICALCREAM
Approved
Mar 1982
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 9h ago · AI intelligence enriched 4d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
LOCOID is a topical cream formulation approved in 1982 for dermatological conditions requiring corticosteroid therapy. The product is a small-molecule corticosteroid indicated for inflammatory skin diseases. It is applied directly to affected skin areas for localized anti-inflammatory and immunosuppressive effects.
LOE Approaching
With LOE approaching, the brand team is likely consolidating and focusing on managed care retention and generic competition mitigation strategies.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on LOCOID offers limited career growth opportunity given its LOE stage and modest linked job count. Roles are primarily defensive, focused on market share retention and managed care navigation rather than innovation or launch strategy.
Brand ManagerField Sales Representative
Worked on LOCOID at Bausch + Lomb? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.